Antithrombotic Strategy Based on Clinical Events and 4D-CT for Patients After TAVR

PHASE4RecruitingINTERVENTIONAL

Enrollment

650

Participants

Timeline

Start Date

July 27, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Transcatheter Aortic Valve ReplacementAntithrombotic TherapyBioprosthetic Valve Thrombosis

Interventions

DRUG

Oral anticoagulation therapy

Vitamin-K antagonists (warfarin)

DRUG

Single antiplatelet therapy

Aspirin

Trial Locations (1)

RECRUITING

Fuwai hospital, Beijing

All Listed Sponsors

lead

China National Center for Cardiovascular Diseases

OTHER_GOV